Академический Документы
Профессиональный Документы
Культура Документы
ISSN- 0975-1491
ResearchArticle
QUANTITATIVEESTIMATIONOFMUPIROCINCALCIUMFROMPHARMACEUTICAL
OINTMENTFORMULATIONBYUVSPECTROPHOTOMETRY
DEEPAKV.BAGESHWAR,AVINASHS.PAWAR,VINEETAV.KHANVILKAR*,VILASRAOJ.KADAM
BharatiVidyapeethsCollegeofPharmacy,CBDBelapur,NaviMumbai.400614,Maharashtra,India.Email:trushali.k@gmail.com
Received:10Feb2010,RevisedandAccepted:12March2010
ABSTRACT
Assay procedure based on UV Spectrophotometry has been developed for the quantitative estimation of Mupirocin calcium from ointment
formulation. The solvent system and wavelength of detection were optimized in order to maximize the sensitivity of the proposed method.
Mupirocin calcium shows the maximum absorbance at 220 nm and the linearity was observed in the concentration range of 216 g/ml. The
developed UV Spectrophotometric method was found to be accurate, sensitive, precise, and reproducible and was successfully applied to a
pharmaceuticalointmentformulationforquantitativeestimationofMupirocincalcium.
Keywords:MupirocinCalcium,UVSpectrophotometry.
INTRODUCTION
Reagents
Preparationofcalibrationcurve
Theobjectiveofpresentworkistodevelopasimple,sensitive,rapid
and economic spectrophotometric method for the quantitative
estimation of mupirocin calcium in bulk and pharmaceutical
ointmentformulation.
Analysisofointmentformulation
MATERIALSANDMETHODS
Instrumentation
A SHIMADZU 1601 UVVISIBLE spectrophotometer with 1.0 cm
matching quartz cells were used for absorbance measurements in
thevisibleandultravioletregions,respectively.TheUVspectrawere
recordedoverthewavelength200300nm.ACYBERLABPHS3DpH
meterwasusedforpHmeasurementofsolventsystem.
Fig.1:UVspectrumofMupirocincalciumin50:50v/vacetonitrilesodiumphosphatebuffer(pH6.4)atmax220nm
86
IntJPharmacyPharmSci
Fig.2:Calibrationcurveformupirocincalcium
Table1:Regressioncharacteristicsoftheproposedmethod
Statisticalparameters
Results
Wavelength220nm
Slope0.12
Intercept 0.029
S.Eofslope
0.0011
S.Eofintercept
0.0023
RegressionequationY=0.2507X0.0337
Correlationcoefficient(r)
0.9994
Y=absorbanceandX=concentrationofthedruging/ml.*Basedonsixcalibrationvalues
Table2:ValidationreportfortheestimationofMupirocincalcium
Analyticalparameters
Accuracy(%)
Precision(%)
Linearity
Specificity(at220nmfor10g/ml)
Limitofdetection*
Limitofquantitation*
Ruggedness(%)
Results
99.960.2263
99.760.1041
216g/ml
1.9910.0073
0.45g/ml
2g/ml
99.870.45
*BasedonS.D.oftheresponseandtheslopeoftheregressioncurve
Recoverystudies
Recovery
SampleLabelclaim
Mean
R.S.DS.E.
Analyticalrecovery(%)
(%w/w)
Puredrug2.0450.032 0.35
0.2079 100.130.23
TBACT 21.9880.012
1.060.971999.650.17
Supirocin21.9790.009
0.860.330999.920.23
RESULTSANDDISCUSSION
Mupirocin calcium showed a good linear relationship in the
concentrationrangeof216g/mlin50:50v/vacetonitrilesodium
phosphate buffer (pH 6.4) solvent system. The calibration curve
yielded the linear regression equation as Y = 0.2507 X 0.0337,
whereYistheabsorbanceandXistheconcentration(g/ml)ofpure
mupirocin calcium solution having high correlation coefficient r2=
0.9994.Theresultsofanalysisofmarketedformulationsareshown
inTable3.Highlevelofprecisionfortheproposedmethodhasbeen
evidenced by the low values of standard deviation (S.D), standard
error(S.E.)andrelativestandarddeviation(R.S.D.).Thepercentage
recoveries values indicate no interference from excipients used in
theformulation.
CONCLUSION
The developed UV spectrophotometric method for the quantitative
estimation of Mupirocin calcium is simple, sensitive and economic.
Thesample recoveriesin bothointmentformulationswereingood
agreementwiththeirrespectivelabelclaimsandthussuggestedthe
validity of the methods and noninterference of formulation
87
8.
88
IntJPharmacyPharmSci